Agilent Technologies (A) Lifted to Buy at ValuEngine

ValuEngine upgraded shares of Agilent Technologies (NYSE:A) from a hold rating to a buy rating in a research report sent to investors on Friday morning.

A number of other analysts have also recently weighed in on A. Morgan Stanley boosted their target price on shares of Agilent Technologies from $84.00 to $86.00 and gave the stock an overweight rating in a research note on Wednesday, October 10th. Goldman Sachs Group reaffirmed a buy rating and set a $82.00 target price (up previously from $77.00) on shares of Agilent Technologies in a research note on Tuesday, September 18th. Zacks Investment Research cut shares of Agilent Technologies from a buy rating to a hold rating in a research note on Tuesday, October 16th. Finally, Deutsche Bank boosted their target price on shares of Agilent Technologies from $77.00 to $80.00 and gave the stock a buy rating in a research note on Wednesday, August 15th. One analyst has rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Agilent Technologies currently has an average rating of Buy and an average target price of $77.44.

Shares of NYSE:A opened at $65.91 on Friday. The company has a market capitalization of $21.02 billion, a P/E ratio of 27.93, a PEG ratio of 2.06 and a beta of 1.35. The company has a current ratio of 3.62, a quick ratio of 3.00 and a debt-to-equity ratio of 0.39. Agilent Technologies has a 1 year low of $60.42 and a 1 year high of $75.00.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Tuesday, August 14th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.04. The business had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.20 billion. Agilent Technologies had a net margin of 6.20% and a return on equity of 18.61%. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period last year, the firm posted $0.59 earnings per share. As a group, equities analysts predict that Agilent Technologies will post 2.71 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 24th. Shareholders of record on Tuesday, October 2nd were paid a dividend of $0.149 per share. The ex-dividend date was Monday, October 1st. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.90%. Agilent Technologies’s payout ratio is presently 25.42%.

In other news, Director Heidi Fields sold 5,482 shares of Agilent Technologies stock in a transaction on Tuesday, September 11th. The shares were sold at an average price of $67.73, for a total transaction of $371,295.86. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Paul N. Clark sold 2,876 shares of Agilent Technologies stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $68.60, for a total transaction of $197,293.60. The disclosure for this sale can be found here.

Several large investors have recently modified their holdings of the company. SRS Capital Advisors Inc. lifted its holdings in Agilent Technologies by 75.9% in the second quarter. SRS Capital Advisors Inc. now owns 1,791 shares of the medical research company’s stock valued at $110,000 after buying an additional 773 shares during the period. Moneta Group Investment Advisors LLC lifted its holdings in Agilent Technologies by 391.7% in the second quarter. Moneta Group Investment Advisors LLC now owns 6,023 shares of the medical research company’s stock valued at $158,000 after buying an additional 4,798 shares during the period. TRUE Private Wealth Advisors acquired a new position in Agilent Technologies in the third quarter valued at $181,000. Bray Capital Advisors lifted its holdings in Agilent Technologies by 12,000.0% in the second quarter. Bray Capital Advisors now owns 3,025 shares of the medical research company’s stock valued at $187,000 after buying an additional 3,000 shares during the period. Finally, AMG National Trust Bank acquired a new position in Agilent Technologies in the third quarter valued at $212,000.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Read More: How can you know how many shares are floating?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply